Akcea, Fresh Off C-Suite Shakeup, Dishes Heart Drug to Pfizer for $250M

Akcea, Fresh Off C-Suite Shakeup, Dishes Heart Drug to Pfizer for $250M

Source: 
Xconomy
snippet: 

Pfizer this morning bought an experimental heart disease drug from Akcea therapeutics, the first move made by the Ionis Pharmaceuticals spinout since the company overhauled its management team last month.